Information Journal Paper
APA:
Copy. (2019). Lentiviral and genome-editing strategies for the treatment of β-hemoglobinopathies. BLOOD, 134(15), 1203-1213. SID. https://sid.ir/paper/783208/en
Vancouver:
Copy. Lentiviral and genome-editing strategies for the treatment of β-hemoglobinopathies. BLOOD[Internet]. 2019;134(15):1203-1213. Available from: https://sid.ir/paper/783208/en
IEEE:
Copy, “Lentiviral and genome-editing strategies for the treatment of β-hemoglobinopathies,” BLOOD, vol. 134, no. 15, pp. 1203–1213, 2019, [Online]. Available: https://sid.ir/paper/783208/en